DMEMEDS shared post via Reuters: U.S. clears AstraZeneca over heart drug trial

LONDON (Reuters) - AstraZeneca said on Tuesday the U.S. government was closing a probe into a major clinical trial used to win marketing approval for its new heart drug Brilinta and no further action was planned. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/k2068Vo3S-s/story01.htm

Read More